Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 7/2018

01.07.2018 | Headache (R Halker, Section Editor)

Women and Migraine: the Role of Hormones

verfasst von: Candice Todd, Ana Marissa Lagman-Bartolome, Christine Lay

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Migraine is a debilitating disease, that is encountered in countless medical offices every day and since it is highly prevalent in women, it is imperative to have a clear understanding of how to manage migraine. There is a growing body of evidence regarding the patterns we see in women throughout their life cycle and how we approach migraine diagnosis and treatment at those times.

Recent Findings

New guidelines regarding safety of medication during pregnancy and lactation are being utilized to help guide management decisions in female migraineurs. There is also new data surrounding the risk of stroke in individuals who suffer from migraine with aura.

Summary

This article seeks to provide an overview of a woman’s migraine throughout her lifetime, the impact of hormones and an approach to management.
Literatur
2.
Zurück zum Zitat Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2017;390:1211–859. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2017;390:1211–859.
3.
Zurück zum Zitat (2018) Headache Classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211. (2018) Headache Classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211.
4.
Zurück zum Zitat Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.CrossRefPubMedPubMedCentral Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210. Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.
7.
Zurück zum Zitat Buse D, Loder E, Gorman J, Stewart W, Reed M, Fanning K, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache: J Head Face Pain. 2013;53:1278–99. Buse D, Loder E, Gorman J, Stewart W, Reed M, Fanning K, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache: J Head Face Pain. 2013;53:1278–99.
8.
Zurück zum Zitat Crawford M, Lehman L, Slater S, Kabbouche M, LeCates S, Segers A, et al. Menstrual migraine in adolescents. Headache: J Head Face Pain. 2009;49:341–7. Crawford M, Lehman L, Slater S, Kabbouche M, LeCates S, Segers A, et al. Menstrual migraine in adolescents. Headache: J Head Face Pain. 2009;49:341–7.
9.
Zurück zum Zitat Martin V, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache: J Head Face Pain. 2006;46:3–23.CrossRef Martin V, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis-part I. Headache: J Head Face Pain. 2006;46:3–23.CrossRef
10.
Zurück zum Zitat •• Vetvik K, MacGregor E. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16:76–87. The authors review sex differences regarding migraine characteristics and treatment. This paper discusses the possible exogenous and endogenous hormonal influences on genes that lead to women experiencing more migraine than men. CrossRefPubMed •• Vetvik K, MacGregor E. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16:76–87. The authors review sex differences regarding migraine characteristics and treatment. This paper discusses the possible exogenous and endogenous hormonal influences on genes that lead to women experiencing more migraine than men. CrossRefPubMed
12.
Zurück zum Zitat ACOG practice bulletin no. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107:1453. ACOG practice bulletin no. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107:1453.
14.
Zurück zum Zitat • Calhoun A, Batur P. Combined hormonal contraceptives and migraine: an update on the evidence. Cleveland Clin J Med. 2017;84:631–8. This article highlights the issues around oral contraceptive use in women migraineurs with and without aura. It discusses the algorithm physicians should use in order to safely prescribe estrogen-containing contraceptives. CrossRef • Calhoun A, Batur P. Combined hormonal contraceptives and migraine: an update on the evidence. Cleveland Clin J Med. 2017;84:631–8. This article highlights the issues around oral contraceptive use in women migraineurs with and without aura. It discusses the algorithm physicians should use in order to safely prescribe estrogen-containing contraceptives. CrossRef
15.
Zurück zum Zitat •• Champaloux S, Tepper N, Monsour M, Curtis K, Whiteman M, Marchbanks P, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Obstet Gynecol Surv. 2017;72:543–5. This article finds a 6-fold increased risk of stroke in women of childbearing age who use combine oral contraceptive medications and suffer from migraine with aura. •• Champaloux S, Tepper N, Monsour M, Curtis K, Whiteman M, Marchbanks P, et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Obstet Gynecol Surv. 2017;72:543–5. This article finds a 6-fold increased risk of stroke in women of childbearing age who use combine oral contraceptive medications and suffer from migraine with aura.
16.
Zurück zum Zitat Tepper N, Whiteman M, Zapata L, Marchbanks P, Curtis K. Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception. 2016;94:630–40.CrossRefPubMed Tepper N, Whiteman M, Zapata L, Marchbanks P, Curtis K. Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception. 2016;94:630–40.CrossRefPubMed
17.
Zurück zum Zitat Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.CrossRefPubMedPubMedCentral Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Tariq N, Tepper S, Kriegler J. Patent foramen ovale and migraine: closing the debate-a review. Headache: J Head Face Pain. 2016;56:462–78.CrossRef Tariq N, Tepper S, Kriegler J. Patent foramen ovale and migraine: closing the debate-a review. Headache: J Head Face Pain. 2016;56:462–78.CrossRef
19.
Zurück zum Zitat Vetvik K, Benth J, MacGregor E, Lundqvist C, Russell M. Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine. Cephalalgia. 2015;35:1261–8.CrossRefPubMed Vetvik K, Benth J, MacGregor E, Lundqvist C, Russell M. Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine. Cephalalgia. 2015;35:1261–8.CrossRefPubMed
20.
Zurück zum Zitat Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep. 2010;14:376–84.CrossRefPubMedPubMedCentral Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep. 2010;14:376–84.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Güven B, Güven H, Çomoğlu S. Clinical characteristics of menstrually related and non-menstrual migraine. Acta Neurologica Belgica. 2017;117:671–6.CrossRefPubMed Güven B, Güven H, Çomoğlu S. Clinical characteristics of menstrually related and non-menstrual migraine. Acta Neurologica Belgica. 2017;117:671–6.CrossRefPubMed
24.
Zurück zum Zitat MacGregor E. Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep. 2009;13:399–403.CrossRefPubMed MacGregor E. Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep. 2009;13:399–403.CrossRefPubMed
25.
Zurück zum Zitat Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.CrossRefPubMedPubMedCentral Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Bergandi F, et al. Treating migraine with contraceptives. Neurol Sci. 2017;38:85–9. Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Bergandi F, et al. Treating migraine with contraceptives. Neurol Sci. 2017;38:85–9.
27.
Zurück zum Zitat Lay C, Broner S. Adolescent issues in migraine: a focus on menstrual migraine. Curr Pain Headache Rep. 2008;12:384–7.CrossRefPubMed Lay C, Broner S. Adolescent issues in migraine: a focus on menstrual migraine. Curr Pain Headache Rep. 2008;12:384–7.CrossRefPubMed
28.
Zurück zum Zitat Warhurst S, Rofe C, Brew B, Bateson D, McGeechan K, Merki-Feld G, et al. Effectiveness of the proestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia. 2017;38:754–64. Warhurst S, Rofe C, Brew B, Bateson D, McGeechan K, Merki-Feld G, et al. Effectiveness of the proestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia. 2017;38:754–64.
29.
Zurück zum Zitat Neri I, Granella F, Nappi R, Manzoni G, Facchinetti F, Genazzani A. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17:31–7.CrossRefPubMed Neri I, Granella F, Nappi R, Manzoni G, Facchinetti F, Genazzani A. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17:31–7.CrossRefPubMed
30.
Zurück zum Zitat Calhoun A. Hormonal contraceptives and migraine with aura-is there still a risk? Headache: J Head Face Pain. 2016;57:184–93.CrossRef Calhoun A. Hormonal contraceptives and migraine with aura-is there still a risk? Headache: J Head Face Pain. 2016;57:184–93.CrossRef
32.
Zurück zum Zitat Jarvis S, Dassan P, Piercy C. Managing migraine in pregnancy. BMJ. 2018:k80. Jarvis S, Dassan P, Piercy C. Managing migraine in pregnancy. BMJ. 2018:k80.
34.
Zurück zum Zitat Grossman T, Robbins M, Govindappagari S, Dayal A. Delivery outcomes of patients with acute migraine in pregnancy: a retrospective study. Headache: J Head Face Pain. 2017;57:605–11.CrossRef Grossman T, Robbins M, Govindappagari S, Dayal A. Delivery outcomes of patients with acute migraine in pregnancy: a retrospective study. Headache: J Head Face Pain. 2017;57:605–11.CrossRef
36.
Zurück zum Zitat • Negro A, Delaruelle Z, Ivanova T, Khan S, Ornello R, Raffaelli B, et al. Headache and pregnancy: a systematic review. J Headache Pain. 2017; https://doi.org/10.1186/s10194-017-0816-0. This article reviews the literature regarding the safety of pharmacological treatment of migraine during both the peri-partum and post-partum period. The authors update readers on the change in safety classifications. • Negro A, Delaruelle Z, Ivanova T, Khan S, Ornello R, Raffaelli B, et al. Headache and pregnancy: a systematic review. J Headache Pain. 2017; https://​doi.​org/​10.​1186/​s10194-017-0816-0. This article reviews the literature regarding the safety of pharmacological treatment of migraine during both the peri-partum and post-partum period. The authors update readers on the change in safety classifications.
37.
Zurück zum Zitat Nezvalová-Henriksen K, Spigset O, Nordeng H. The effects of codeine on pregnancy outcome: results from a large population-based cohort study. Reprod Toxicol. 2011;31:263–3. Nezvalová-Henriksen K, Spigset O, Nordeng H. The effects of codeine on pregnancy outcome: results from a large population-based cohort study. Reprod Toxicol. 2011;31:263–3.
38.
Zurück zum Zitat Marchenko A, Etwel F, Olutunfese O, Nickel C, Koren G, Nulman I. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache: J Head Face Pain. 2015;55:490–501.CrossRef Marchenko A, Etwel F, Olutunfese O, Nickel C, Koren G, Nulman I. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache: J Head Face Pain. 2015;55:490–501.CrossRef
39.
Zurück zum Zitat Harris G, Wood M, Ystrom E, Nordeng H. Prenatal triptan exposure and neurodevelopmental outcomes in 5-year-old children: follow-up from the Norwegian mother and child cohort study. Paediatr Perinat Epidemiol. 2018; https://doi.org/10.1111/ppe.12461. Harris G, Wood M, Ystrom E, Nordeng H. Prenatal triptan exposure and neurodevelopmental outcomes in 5-year-old children: follow-up from the Norwegian mother and child cohort study. Paediatr Perinat Epidemiol. 2018; https://​doi.​org/​10.​1111/​ppe.​12461.
40.
Zurück zum Zitat Hoshiyama E, Tatsumoto M, Iwanami H, Saisu A, Watanabe H, Inaba N, et al. Postpartum migraines: a long-term prospective study. Intern Med. 2012;51:3119–23. Hoshiyama E, Tatsumoto M, Iwanami H, Saisu A, Watanabe H, Inaba N, et al. Postpartum migraines: a long-term prospective study. Intern Med. 2012;51:3119–23.
41.
Zurück zum Zitat Davanzo R, Bua J, Paloni G, Facchina G. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014;70:1313–24.CrossRefPubMed Davanzo R, Bua J, Paloni G, Facchina G. Breastfeeding and migraine drugs. Eur J Clin Pharmacol. 2014;70:1313–24.CrossRefPubMed
42.
Zurück zum Zitat Hutchinson S, Marmura M, Calhoun A, Lucas S, Silberstein S, Peterlin B. Use of common migraine treatments in breast-feeding women: a summary of recommendations. Headache: J Head Face Pain. 2013;53:614–27.CrossRef Hutchinson S, Marmura M, Calhoun A, Lucas S, Silberstein S, Peterlin B. Use of common migraine treatments in breast-feeding women: a summary of recommendations. Headache: J Head Face Pain. 2013;53:614–27.CrossRef
43.
Zurück zum Zitat Ibrahimi K, Couturier E, MaassenVanDenBrink A. Migraine and perimenopause. Maturitas. 2014;78:277–80.CrossRefPubMed Ibrahimi K, Couturier E, MaassenVanDenBrink A. Migraine and perimenopause. Maturitas. 2014;78:277–80.CrossRefPubMed
44.
Zurück zum Zitat •• Martin V, Pavlovic J, Fanning K, Buse D, Reed M, Lipton R. Perimenopause and menopause are associated with high frequency headache in women with migraine: results of the American Migraine Prevalence and Prevention Study. Headache. J Head Face Pain. 2016;56:292–305. This is a cross-sectional study that reviews the frequency of headache during the various stages of menopause, particularly the perimenopausal period. CrossRef •• Martin V, Pavlovic J, Fanning K, Buse D, Reed M, Lipton R. Perimenopause and menopause are associated with high frequency headache in women with migraine: results of the American Migraine Prevalence and Prevention Study. Headache. J Head Face Pain. 2016;56:292–305. This is a cross-sectional study that reviews the frequency of headache during the various stages of menopause, particularly the perimenopausal period. CrossRef
46.
Zurück zum Zitat Marino J, McNamara H, Hickey M. Managing menopausal symptoms after cancer: an evidence-based approach for primary care. Med J Aust. 2018;208:127–32.CrossRefPubMed Marino J, McNamara H, Hickey M. Managing menopausal symptoms after cancer: an evidence-based approach for primary care. Med J Aust. 2018;208:127–32.CrossRefPubMed
Metadaten
Titel
Women and Migraine: the Role of Hormones
verfasst von
Candice Todd
Ana Marissa Lagman-Bartolome
Christine Lay
Publikationsdatum
01.07.2018
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 7/2018
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-018-0845-3

Weitere Artikel der Ausgabe 7/2018

Current Neurology and Neuroscience Reports 7/2018 Zur Ausgabe

Behavior (H S Kirshner, Section Editor)

Thalamic Lesions and Aphasia or Neglect

Demyelinating Disorders (J Bernard and M Cameron, Section Editors)

Caring for Women with Multiple Sclerosis Across the Lifespan

Sleep (M Thorpy and M Billiard, Section Editors)

Narcolepsy Associated with Pandemrix Vaccine

Sleep (M Thorpy and M Billiard, Section Editors)

The Sleep Disorder in Anti-lgLON5 Disease

Demyelinating Disorders (J Bernard and M Cameron, Section Editors)

Behçet’s Syndrome and Nervous System Involvement

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.